TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | 27.92%-807.81M | 17.60%-576.7M | 27.32%-344.93M | -238.47%-4.29B | -2.99%-1.12B | 6.50%-699.92M | -27.16%-474.61M | -6.29%-1.27B | -23.90%-1.09B | -29.69%-748.56M |
Profit adjustment | ||||||||||
Investment loss (gain) | ---- | ---- | ---- | -101.11%-110K | ---- | ---- | ---- | 926.24%9.93M | ---- | ---- |
Impairment and provisions: | ---- | ---- | ---- | 13,262.03%3.03B | ---- | ---- | ---- | 125.31%22.69M | ---- | ---- |
-Other impairments and provisions | ---- | ---- | ---- | 13,262.03%3.03B | ---- | ---- | ---- | 125.31%22.69M | ---- | ---- |
Asset sale loss (gain): | ---- | ---- | ---- | -13.55%-17.06M | ---- | ---- | ---- | -752.24%-15.03M | ---- | ---- |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---5.01M | ---- | ---- | ---- | ---- | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | 19.79%-12.05M | ---- | ---- | ---- | -752.24%-15.03M | ---- | ---- |
Depreciation and amortization: | 0.67%2.75B | -0.36%1.8B | 0.82%895.3M | 9.81%3.67B | 9.96%2.74B | 8.13%1.81B | 8.00%888.05M | 18.71%3.34B | 23.50%2.49B | 30.48%1.67B |
-Depreciation | 1.48%2.64B | 0.78%1.73B | 1.59%856.74M | 10.37%3.52B | 9.92%2.6B | 9.16%1.72B | 7.88%843.36M | 21.86%3.19B | 26.14%2.37B | 33.35%1.57B |
-Other depreciation and amortization | -15.30%111.79M | -22.23%69.93M | -13.72%38.56M | -1.70%152.29M | 10.71%131.98M | -8.43%89.92M | 10.22%44.69M | -22.57%154.92M | -12.83%119.21M | -2.95%98.19M |
Special items | -56.82%117.29M | -14.72%129.9M | 5.52%88.87M | 68.27%148.94M | -6.74%271.64M | -22.68%152.33M | -13.60%84.22M | -76.47%88.51M | -11.37%291.27M | -10.91%197M |
Operating profit before the change of operating capital | 9.38%2.06B | 7.48%1.35B | 28.45%639.24M | 16.76%2.55B | 11.57%1.89B | 12.49%1.26B | -8.94%497.66M | 8.59%2.18B | 15.44%1.69B | 21.08%1.12B |
Change of operating capital | ||||||||||
Accounts receivable (increase)decrease | ---- | ---- | ---- | 76.97%-156.33M | ---- | ---- | ---- | -1,686.78%-678.83M | ---- | ---- |
Accounts payable increase (decrease) | ---- | ---- | ---- | -179.16%-52.41M | ---- | ---- | ---- | 176.68%66.2M | ---- | ---- |
prepayments (increase)decrease | ---- | ---- | ---- | 416.47%94.43M | ---- | ---- | ---- | 151.95%18.28M | ---- | ---- |
Cash from business operations | 9.38%2.06B | 7.48%1.35B | 28.45%639.24M | 53.23%2.44B | 11.57%1.89B | 12.49%1.26B | -8.94%497.66M | -14.15%1.59B | 15.44%1.69B | 21.08%1.12B |
Other taxs | ---- | ---- | ---- | -132.87%-388.73M | ---- | ---- | ---- | 287.24%1.18B | ---- | ---- |
Special items of business | -41.79%-1.09B | -56.60%-1.02B | -21.91%-764.22M | -78.84%18.18M | -397.21%-770.61M | -357.12%-654.37M | 20.78%-626.84M | 556.74%85.92M | 138.73%259.28M | 143.44%254.5M |
Net cash from operations | -13.00%970.78M | -45.61%329.27M | 3.26%-124.97M | -27.74%2.07B | -42.78%1.12B | -55.95%605.42M | 47.22%-129.18M | 137.90%2.86B | 145.22%1.95B | 305.35%1.37B |
Cash flow from investment activities | ||||||||||
Sale of fixed assets | ---- | ---- | ---- | -57.44%18.57M | ---- | ---- | ---- | 2,991.28%43.62M | ---- | ---- |
Purchase of fixed assets | -30.78%-6.45B | -2.86%-3.56B | 21.89%-1.6B | 23.26%-6.02B | 12.93%-4.94B | 11.49%-3.46B | 5.53%-2.04B | 19.10%-7.85B | 23.25%-5.67B | 5.72%-3.91B |
Sale of subsidiaries | ---- | ---- | ---- | --23.63M | ---- | ---- | ---- | ---- | ---- | ---- |
Cash on investment | 70.06%-70.79M | 50.30%-70.79M | ---- | 93.27%-234.85M | 93.20%-236.45M | 95.40%-142.45M | 94.54%-151.26M | 3.98%-3.49B | 3.39%-3.48B | -3.22%-3.1B |
Other items in the investment business | ---- | ---- | ---- | -687.88%-111.7M | ---- | ---- | ---- | 105.02%19M | ---- | ---- |
Net cash from investment operations | -26.17%-6.53B | -0.75%-3.63B | 27.28%-1.6B | 43.89%-6.33B | 43.44%-5.17B | 48.61%-3.6B | 55.53%-2.19B | 17.65%-11.27B | 16.58%-9.14B | 1.97%-7B |
Net cash before financing | -36.95%-5.55B | -10.13%-3.3B | 25.94%-1.72B | 49.38%-4.26B | 43.61%-4.06B | 46.82%-2.99B | 55.14%-2.32B | 32.61%-8.42B | 29.24%-7.19B | 17.28%-5.63B |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | ---- | ---- | -10.94%10.59B | ---- | ---- | ---- | -26.54%11.89B | ---- | ---- |
Refund | ---- | ---- | ---- | 14.89%-8.16B | ---- | ---- | ---- | -57.65%-9.59B | ---- | ---- |
Issuing shares | ---- | ---- | ---- | 0.25%3.93B | ---- | ---- | ---- | --3.92B | ---- | ---- |
Absorb investment income | ---- | ---- | ---- | --44.19M | ---- | ---- | ---- | ---- | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | -1,434.26%-2.47B | ---- | ---- | ---- | 19.19%-161M | ---- | ---- |
Other items of the financing business | 167.47%7.4B | 134.82%5.46B | -58.14%1.62B | 406.15%198.83M | -30.80%2.77B | -11.19%2.32B | -15.97%3.87B | 96.28%-64.95M | -0.11%4B | -9.35%2.62B |
Net cash from financing operations | 167.47%7.4B | 134.82%5.46B | -58.14%1.62B | -35.29%3.14B | -30.80%2.77B | -11.19%2.32B | -15.97%3.87B | -40.19%4.86B | -0.11%4B | -9.35%2.62B |
Effect of rate | -104.77%-7.14M | -86.88%20.97M | -139.73%-9.91M | -62.93%154.3M | -64.79%149.6M | -49.52%159.82M | 521.32%24.94M | 535.62%416.2M | 507.21%424.85M | 349.42%316.61M |
Net Cash | 242.74%1.84B | 421.55%2.16B | -106.32%-98.11M | 68.59%-1.12B | 59.63%-1.29B | 77.74%-671.05M | 374.21%1.55B | 18.54%-3.56B | 48.14%-3.2B | 23.11%-3.01B |
Begining period cash | -10.85%7.92B | -10.85%7.92B | -10.85%7.92B | -26.15%8.88B | -26.15%8.88B | -26.15%8.88B | -26.15%8.88B | -27.08%12.03B | -27.08%12.03B | -27.08%12.03B |
Items Period | ---- | ---- | ---- | ---- | ---598K | ---274K | ---2.24M | ---- | ---- | ---- |
Cash at the end | 26.00%9.75B | 20.62%10.1B | -25.31%7.81B | -10.85%7.92B | -16.35%7.74B | -10.27%8.37B | -8.71%10.46B | -26.15%8.88B | -9.48%9.25B | -25.05%9.33B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS |
Audit Opinions | -- | -- | -- | Unaudited opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | KPMG | -- | -- | -- | KPMG | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.